Physician profile
Muhammad A Ashraf
NPI 1679737076
$299.70
in general payments reported to CMS, 2019-2025
9 companies · $26.76 in 2025
The $26.76 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $61.17 · 2021: $11.84 · 2025: $26.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $71.92 | 2019 | |
| Fresenius USA Marketing, INC. | $64.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $49.26 | 2019-2020 | |
| Novo Nordisk INC | $26.76 | 2025 | Ozempic, Rybelsus |
| Amgen INC. | $23.27 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $20.93 | 2019 | |
| Daiichi Sankyo INC. | $18.13 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $13.38 | 2019 | |
| Glaxosmithkline, LLC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ashraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.